Zobrazeno 1 - 7
of 7
pro vyhledávání: '"E. Lynne Kelley"'
Autor:
E. Lynne Kelley, Richard H. Smith, Gillian Corcoran, Sandra Nygren, Mary V. Jacoski, Andrea Fernandes
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 1915-1922 (2021)
Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick injuries. However, development of a safe, reliable needle-free device optimized for at-home use ha
Externí odkaz:
https://doaj.org/article/ccec6f02949d4d7d8bfde4fe215df9e2
Autor:
Mary V. Jacoski, Andrea Fernandes, Richard H. Smith, Sandra Nygren, Gillian Corcoran, E. Lynne Kelley
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 28, Iss 1, Pp 1915-1922 (2021)
article-version (VoR) Version of Record
Drug Delivery, Vol 28, Iss 1, Pp 1915-1922 (2021)
Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick injuries. However, development of a safe, reliable needle-free device optimized for at-home use ha
Autor:
E. Lynne Kelley, Andrea Fernandes, Marc Pelletier, Eri A. Takami, Christine Emery, Bobby Dyer, Mary V. Jacoski, Valery Lozko, Bart Burgess, Richard H. Smith
Publikováno v:
PDA journal of pharmaceutical science and technology. 76(6)
Many medical conditions require chronic treatment with subcutaneous injectable biologics often exceeding 1.0 mL. However, subcutaneous administration of volumes of 2.0 mL or greater using a standard needle and syringe or auto-injector proves challeng
Autor:
Beverly A. Teicher, Narimanne El-Zein, E. Lynne Kelley, Kathryn Evans, Connor D. Jones, Richard B. Lock, Malcolm A. Smith, Sarah Beaussant-Cohen, Stephen W. Erickson
Publikováno v:
Molecular Cancer Therapeutics. 18:C004-C004
Introduction: While overall survival for pediatric acute lymphoblastic leukemia (ALL) now approaches 90%, new treatment options are urgently required for certain high-risk subtypes including BCR-ABL1 or TCF3-HLF ALL, and relapsed T-cell ALL (T-ALL).
Publikováno v:
Catheterization and Cardiovascular Interventions. 72:853-862
Objective The multicenter, single-arm RENAISSANCE trial evaluated outcomes in patients with progressive atherosclerotic renal artery stenosis (ARAS) treated with the Express™ Renal Premounted Stent System (Boston Scientific, Natick, MA). Background
A randomized trial of a skin sealant to reduce the risk of incision contamination in cardiac surgery
Autor:
Susan G. Oslund, Pascal M. Dohmen, Paulo Manuel Pêgo-Fernandes, William A. Cooper, Abelardo Silva von Eckardstein, Chong H. Lim, E. Lynne Kelley
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Background Immobilizing skin microbes is a rational approach to reducing contamination of surgical sites by endogenous microorganisms. Methods This randomized, controlled, parallel-group, multicenter, open-label clinical trial (ClinicalTrials.gov NCT
Autor:
Rocha-Singh K; Prairie Vascular Institute, Springfield, Illionis 62719, USA. ksingh@prairieheart.com, Jaff MR, Lynne Kelley E
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2008 Nov 15; Vol. 72 (6), pp. 853-62.